Creative Details

Quality Score: 5/10

The advertisement promotes a program called 'Advancing Access' for the medication Descovy, highlighting that it can be obtained at no cost each month for eligible individuals.

Creative Information

CID:aafc2476-e16e-4f2b-ba60-a503ed81c4b5
CRID:89_235545
Domain:gilead.com
Seat:DInt
Size:300x150
Bid:$10.34
Timestamp:12/22/2025, 5:36:53 PM
Declared IAB Categories:

    Analysis

    6 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess12/22/2025, 5:37:37 PM5.80s
    adomain_analysissuccess12/22/2025, 5:37:35 PM3.01s
    adomain_capturesuccess12/22/2025, 5:37:32 PM0.17s
    ad_rendersuccess12/22/2025, 5:37:31 PM36.81s
    brand_mappingsuccess12/22/2025, 5:36:53 PM0.09s
    video_analysissuccess12/22/2025, 5:37:32 PM1.08s

    Analysis Results

    Ad Format: video

    Sub Format: video

    Brands: Gilead

    Sensitive:Pharmaceutical Products
    Quality:Adomain not match landing page domain
    Size:300x150
    Data Transferred:2159.69 KB
    Render Time:22.21 Seconds
    Video Duration:30.0 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Personal Finance (IAB13)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Business (IAB3)
    • Health & Fitness (IAB7)
    • Science (IAB15)
    Domain Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Landing Page:
    Total Ad Size:6736.52 KB
    Requests Made:
    URLSize (KB)
    https://r5---sn-ab5l6ny7.c.2mdn.net/videoplayback/id/f4ed5e666e53b7af/itag/692/source/web_video_ads/xpc/EgVovf3BOg%3D%3D/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3883925300/sparams/acao,ctier,expire,id,ip,ipbits,itag,met,mh,mip,mm,mn,ms,mv,mvi,pl,rms,source,xpc/signature/64EEF719BBF1F625644A02FC96A6869AA793EA65.66433E9B55352E5D4AF12F098820A307A699D941/key/cms1/cms_redirect/yes/met/1766425015,/mh/uO/mip/54.89.42.183/mm/42/mn/sn-ab5l6ny7/ms/onc/mt/1766424548/mv/m/mvi/5/pl/23/rms/onc,onc/file/file.mp44576.71
    https://r1---sn-ab5sznzr.c.2mdn.net/videoplayback/id/f4ed5e666e53b7af/itag/18/source/web_video_ads/xpc/EgVovf3BOg%3D%3D/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3883925300/sparams/acao,ctier,expire,id,ip,ipbits,itag,met,mh,mip,mm,mn,ms,mv,mvi,pl,rms,source,xpc/signature/4F9A91E1183564FE38E4419DA7BF154BBEC806FC.446A8B390D4F352D69367001CE17CAF916377F04/key/cms1/cms_redirect/yes/met/1766425015,/mh/uO/mip/54.89.42.183/mm/42/mn/sn-ab5sznzr/ms/onc/mt/1766424785/mv/m/mvi/1/pl/23/rms/onc,onc/file/file.mp42146.19
    https://ad.doubleclick.net/ddm/pfadx/N1277702.3848558MATTERKIND/B32827772.426649227;sz=0x0;ord=[timestamp];dc_lat=;dc_rdid=;tag_for_child_directed_treatment=;tfua=;dc_tdv=1;dcmt=text/xml;dc_sdk_apis=[APIFRAMEWORKS];dc_omid_p=[OMIDPARTNER];dc_vast=3;gdpr=AUDIT;gdpr_consent=AUDIT;dc_mpos=[BREAKPOSITION];ltd=13.45
    https://thrtle.com/insync?ad_id=619366059&agency_id=initiative&brand_id=700&campaign_id=32827772&creative_id=231221699&keyword=%7BVALUE%7D&pharma=gilead&placement_id=426649227&site_id=6200436&vxii_pid=12&vxii_pid1=40003&vxii_rcid=3af48152-3f98-42b2-81a7-bbe3fdcac49a0.04
    https://ade.googlesyndication.com/ddm/activity/dc_oe=ChMI8PS5_N3RkQMVAgpoCB04uh14EAAYACDD06BuSAFQOljq6gFg_NLTD2iLzbjLAXj8vOoE;dc_eps=AHas8cDS_VJCrahFAHsCS0rI9mlPXgB_A7acul_eF-Ju3yWYKXlczKPaLtmFMxfZ2oQ0_ySELC_joRE6Nzh7k7qDTQM;met=1;ecn1=1;etm1=0;eid1=11;0.04
    https://ade.googlesyndication.com/ddm/activity/dc_oe=ChMI8PS5_N3RkQMVAgpoCB04uh14EAAYACDD06BuSAFQOljq6gFg_NLTD2iLzbjLAXj8vOoE;dc_eps=AHas8cDS_VJCrahFAHsCS0rI9mlPXgB_A7acul_eF-Ju3yWYKXlczKPaLtmFMxfZ2oQ0_ySELC_joRE6Nzh7k7qDTQM;met=1;ecn1=1;etm1=0;eid1=960584;0.04
    https://ade.googlesyndication.com/ddm/activity/dc_oe=ChMI8PS5_N3RkQMVAgpoCB04uh14EAAYACDD06BuSAFQOljq6gFg_NLTD2iLzbjLAXj8vOoE;dc_eps=AHas8cDS_VJCrahFAHsCS0rI9mlPXgB_A7acul_eF-Ju3yWYKXlczKPaLtmFMxfZ2oQ0_ySELC_joRE6Nzh7k7qDTQM;met=1;ecn1=1;etm1=0;eid1=18;0.04
    https://gcdn.2mdn.net/videoplayback/id/f4ed5e666e53b7af/itag/18/source/web_video_ads/xpc/EgVovf3BOg%3D%3D/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3883925300/sparams/id,itag,source,xpc,ctier,acao,ip,ipbits,expire/signature/AE2A661EA25DC4006AD1034BDEDF909856C030DF.7B7C858F8D02B2E821AA5FD8E82F4CD44A555EA9/key/ck2/file/file.mp40.00
    https://gcdn.2mdn.net/videoplayback/id/f4ed5e666e53b7af/itag/692/source/web_video_ads/xpc/EgVovf3BOg%3D%3D/ctier/L/acao/yes/ip/0.0.0.0/ipbits/0/expire/3883925300/sparams/id,itag,source,xpc,ctier,acao,ip,ipbits,expire/signature/7E92F3C30D4136B2E6FF562FB1606229667632F8.6FA62FDD9144489FAC4F4800A3F13DA116E6A564/key/ck2/file/file.mp40.00
    https://thrtle.com/insync?vxii_pid=40003&pharma=gilead&agency_id=initiative&brand_id=700&site_id=6200436&placement_id=426649227&keyword={VALUE}&campaign_id=32827772&ad_id=619366059&creative_id=2312216990.00

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2Creative Screenshot 3